Press Releases

Press Releases

January 10, 2021
Record Testing Revenue, Adopters and AVISE CTD ® Volumes SAN DIEGO , Jan. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported preliminary, unaudited financial results for
January 5, 2021
SAN DIEGO , Jan. 05, 2021 (GLOBE NEWSWIRE) -- Exagen Inc.  (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the 2021 ICR Conference , which takes place January